Firstpost
  • Home
  • Video Shows
    Vantage Firstpost America Firstpost Africa First Sports
  • World
    US News
  • Explainers
  • News
    India Opinion Cricket Tech Entertainment Sports Health Photostories
  • Asia Cup 2025
Apple Incorporated Modi ji Justin Trudeau Trending

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit
Trending:
  • Charlie Kirk shot dead
  • Nepal protests
  • Russia-Poland tension
  • Israeli strikes in Qatar
  • Larry Ellison
  • Apple event
  • Sunjay Kapur inheritance row
fp-logo
Performance-enhancing drug used by Lance Armstrong is not effective, suggests study
Whatsapp Facebook Twitter
Whatsapp Facebook Twitter
Apple Incorporated Modi ji Justin Trudeau Trending

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit

Performance-enhancing drug used by Lance Armstrong is not effective, suggests study

Press Trust of India • July 3, 2017, 21:47:53 IST
Whatsapp Facebook Twitter

Erythropoietin (EPO), a doping drug used by American cyclist Lance Armstrong which cost him seven Tour de France titles, may have little effect on performance of athletes, a study has found.

Advertisement
Subscribe Join Us
Choose
Firstpost on Google
Choose
Firstpost on Google
Performance-enhancing drug used by Lance Armstrong is not effective, suggests study

London: Erythropoietin (EPO), a doping drug that was used by American cyclist Lance Armstrong - for which he was stripped of his seven Tour de France titles - may have little effect on performance of athletes, a study has found. [caption id=“attachment_1230225” align=“alignleft” width=“380”] ![File image of American cyclist Lance Armstrong. AP](https://images.firstpost.com/wp-content/uploads/2013/11/LanceArmstrong-AP-2.jpg) File image of American cyclist Lance Armstrong. AP[/caption] One of the most celebrated athletes, the road racing cyclist Armstrong was the 1993 professional world champion, and had won the Tour de France a record seven consecutive times from 1999 to 2005. However, in 2012, he was banned from sanctioned Olympic sports for life and stripped off his seven Tour de France titles after he confessed to using the drug EPO. Researchers from Centre for Human Drug Research in the Netherlands conducted a trial on about 48 well-trained non- professional male cyclists aged between 18 and 50 years. They found that while performance was improved in high intensity tests, endurance and road race performances were similar for those who took the drug rHuEPO and those who did not. They found that the drug led to elevated levels of haemoglobin and adhesion molecules which could potentially increase the risk of thrombosis. In the trial, half of the participants were given weekly injections of rHuEPO, and half were given a placebo (saline solution) over 8 weeks. The aim was to increase the levels of haemoglobin in the participants of the rHuEPO group by 10-15 per cent compared to the start of the study. The doses used were consistent with known practises in professional cycling. The trial involved a series of tests to evaluate different types of performance parameters. The first test involved a ramp test, where pedalling resistance was increased every 5 minutes until exhaustion (taking between 30-50 minutes). The second test involved a 45 minute endurance test at the highest power output. The final test, 12 days after the final injections, involved a 110 kilometre (km) cycle followed by a 21.5 km road-race up Mont Ventoux, which often features in the Tour de France race. Mean haemoglobin concentrations, and performance parameters in the high-intensity laboratory test were higher in the rHuEPO group compared to placebo. Gross efficiency, heart rate and other respiratory parameters did not differ between groups. In the endurance tests, mean power output, oxygen consumption and Mont Ventoux race times did not differ between groups. The same was true for cycling economy, mean heart rate, and lactate levels, researchers said. There was no difference in adverse events between the two groups, however the endothelial function markers E-selectin and P-selectin were significantly increased in the rHuEPO group, potentially increasing the risk of thrombosis. “We found that while rHuEPO increased performance in a laboratory setting on high intensity tests, the differences largely disappeared in endurance tests, and were undetectable in a real-world cycling race,” said Jules Heuberger from the Centre for Human Drug Research.

Tags
Cycling Tour de France Lance Armstrong SportsTracker Olympic EPO Mont Ventoux
  • Home
  • Sports
  • Performance-enhancing drug used by Lance Armstrong is not effective, suggests study
End of Article
Latest News
Find us on YouTube
Subscribe
  • Home
  • Sports
  • Performance-enhancing drug used by Lance Armstrong is not effective, suggests study
End of Article

Impact Shorts

WWE SummerSlam 2025 Night 2 results: Cody Rhodes beats John Cena in wild title match

WWE SummerSlam 2025 Night 2 results: Cody Rhodes beats John Cena in wild title match

Brock Lesnar's return headlines Night Two of WWE Summerslam Cody Rhodes defeats John Cena to become the Undisputed WWE Champion Becky Lynch defeats Lyra Valkyria to stay Women’s Intercontinental Champion.

More Impact Shorts

Top Shows

Vantage Firstpost America Firstpost Africa First Sports
Enjoying the news?

Get the latest stories delivered straight to your inbox.

Subscribe
Latest News About Firstpost
Most Searched Categories
  • Web Stories
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Tech/Auto
  • Entertainment
  • IPL 2025
NETWORK18 SITES
  • News18
  • Money Control
  • CNBC TV18
  • Forbes India
  • Advertise with us
  • Sitemap
Firstpost Logo

is on YouTube

Subscribe Now

Copyright @ 2024. Firstpost - All Rights Reserved

About Us Contact Us Privacy Policy Cookie Policy Terms Of Use
Home Video Shorts Live TV